Although both amyloid and tau abnormalities are strongly related such that elevated tau is very uncommon among Aβ- individuals, there is substantial variability in the magnitude of tau PET uptake within Aβ+ individuals [12, 15–20], highlighting that additional factors beyond amyloid contribute to downstream tau accumulation. The gene discussed is MAPT; the disease is amyloidosis.